Your browser doesn't support javascript.
loading
A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer.
Wu, Qing; Tao, Xuan; Luo, Yang; Zheng, Shiyao; Lin, Nan; Xie, Xianhe.
Affiliation
  • Wu Q; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Road, Fuzhou, 350005, China.
  • Tao X; Department of Oncology, National Regional Medical Center, Binhai Campus of The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China.
  • Luo Y; Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Zheng S; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Road, Fuzhou, 350005, China.
  • Lin N; College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, Fujian, China.
  • Xie X; Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
BMC Cancer ; 23(1): 776, 2023 Aug 18.
Article in En | MEDLINE | ID: mdl-37596527

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom